MedPath

Sexual Functions and Covid-19

Not Applicable
Completed
Conditions
Covid19
Sexual Behavior
Interventions
Behavioral: Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)
Registration Number
NCT05018065
Lead Sponsor
Gaziosmanpasa Research and Education Hospital
Brief Summary

Sexual health is one the important components of life quality. The aim of this study is to compare sexual dysfunction of women who survived Covid-19 and who didn't undergo Covid-19.

Detailed Description

With identifying a new type of coronavirus, the infection disease known as Coronavirus disease-2019 (Covid-19) is still effective worldwide. Within the frame of the description that the health is "a complete physical, mental and social welfare," many physical and mental modality may be expected due to the pandemic and the measures against pandemic. Among them, sexual health is one of the basic indicative factors of human welfare. There are few data on sexual dysfunctions from the previous clinic pandemic experiences. From the very early stages of Covid-19 pandemic, health systems and researches focused on mortalities and short-term morbidities. Although there are similar studies about effects of pandemic on sexual behaviors of general community, there is no comparative study about the effects on sexual functions of women survived from Covid-19 and women having no Covid-19 history, yet. This study aims to compare women survived from Covid-19 and women having no Covid-19 history and having similar characteristics in terms of sexual dysfunctions.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
101
Inclusion Criteria
  • previously diagnosed for mild - medium Covid-19 infection and had ambulatory care
  • being sexually active
Exclusion Criteria
  • having psychiatric disease
  • having any malignity
  • having endometriosis
  • having a gynecologic surgery history
  • having a previous sexual dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
50 women previously diagnosed with mild - medium Covid-19 and had ambulatory careWomen sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)
51 women having no Covid-19 historyWomen sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)
Primary Outcome Measures
NameTimeMethod
Sexual function assesment of women previously diagnosed with mild - medium Covid-19 and comparision of results with helath women6 months

Sexual function assesment of women is done by using Female Sexual Functioning Index (FSFI).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saglık Bilimleri University Istanbul Gaziosmanpa Trainig and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath